highperformr logo

AXON Neuroscience's Overview

Total employees31
HeadquartersBratislava
Founded1999

Axon Neuroscience SE is a clinical-stage biotechnology company focused on the development of peptide-based vaccines and therapies against Alzheimer's disease and other tau-related neurodegenerative disorders. Their lead candidate, AADvac1, is an active vaccine designed to target pathological tau proteins, which are a hallmark of Alzheimer's disease. The company's mission is to bring effective treatments and diagnostic tools to patients suffering from these devastating conditions, leveraging deep expertise in immunology and neuroscience.

Where is AXON Neuroscience's Headquarters?

HQ Function

The headquarters serves as the central hub for research and development, clinical trial management, corporate strategy, and administrative operations.

Notable Features:

While specific architectural details are not widely publicized, the facility likely includes advanced laboratory spaces for biochemical and immunological research, as well as office areas for its scientific, clinical, and administrative teams.

Work Culture:

The work culture at Axon Neuroscience SE is likely research-intensive, collaborative, and mission-driven, with a strong focus on scientific innovation and addressing the urgent unmet medical needs in neurodegenerative diseases. Employees are typically highly skilled scientists, clinicians, and professionals dedicated to drug discovery and development.

HQ Significance:

The Bratislava headquarters is significant as it anchors Axon's R&D activities in Central Europe, allowing it to draw on regional scientific talent and collaborate with European research institutions and clinical sites for its trials.

Values Reflected in HQ: The headquarters likely reflects values of innovation, scientific excellence, precision, and a commitment to developing treatments for neurodegenerative diseases.

Location:

While Axon Neuroscience SE's primary operations are based in Bratislava, Slovakia, its clinical trials and research collaborations often extend internationally. The company has engaged with clinical trial sites across various European countries to ensure diverse patient recruitment for its studies on Alzheimer's disease. Its scientific contributions and potential therapeutic impact are global in scope, addressing a worldwide health challenge.

Street Address:

Dvorakovo nabrezie 10

City:

Bratislava

State/Province:

Bratislava Region

Country:

Slovakia

AXON Neuroscience's Global Presence

Buying Intent Signals for AXON Neuroscience

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of AXON Neuroscience

As of April 2025, AXON Neuroscience' leadership includes:

Michal Fresser - Chief Executive Officer
Prof. Michal Novak, MD, DSc, dr.hc. mult. - Founder & Chairman of the Scientific Advisory Board
Norbert Žilka, DVM, PhD, DSc - Chief Scientific Officer
Roman Koci, PhD, MBA - Chief Operating Officer
Matej Ondrus - Chief Financial Officer

Investors of AXON Neuroscience

AXON Neuroscience has been backed by several prominent investors over the years, including:

IPM Group (Majority Shareholder)
Slovak Investment Holding (SIH - via European Investment Bank funds)
Individual private investors

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

Based on publicly available information, there have been no major widely reported executive hires or exits at Axon Neuroscience SE in the last 12-18 months. The leadership team appears relatively stable as of late 2023/early 2024. Roman Koci joined as COO and Matej Ondrus as CFO in 2022, which is slightly outside the 12-month window but represents recent significant additions.

Technology (Tech Stack) used by AXON Neuroscience

Discover the tools AXON Neuroscience uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

AXON Neuroscience Email Formats and Examples

Axon Neuroscience SE likely uses common corporate email formats. Based on observed patterns in the industry and executive communications, the most probable formats are [first_initial][last]@[domain] or [first].[last]@[domain].

[first_initial][last]@axon-neuroscience.com or [first].[last]@axon-neuroscience.com

Format

mfresser@axon-neuroscience.com

Example

80%

Success rate

News and media

PR Newswire2023-03-07

Axon Neuroscience Announces Publication of Positive Results from its Phase I First-in-Human Study of AADcovI, a Novel Active Vaccine Against COVID-19

Axon Neuroscience announced the publication of positive results from its Phase I study of AADcovI, a peptide-based vaccine candidate against COVID-19. The study, published in Alzheimer's & Dementia: Translational Research & Clinical Interventions, demonstrated that AADcovI was safe, well-tolerated, and induced a robust neutralizing antibody response in elderly participants....more

Axon Neuroscience Website (Press Release)2022-10-27

Axon Neuroscience SE Appoints Roman Koci as Chief Operating Officer

Axon Neuroscience SE announced the appointment of Roman Koci, PhD, MBA, as its new Chief Operating Officer (COO). This strategic move aims to strengthen the company's operational capabilities as it advances its pipeline of treatments for neurodegenerative diseases....more

Alzheimer's Research UK2021-07-29

Promising results for Alzheimer's vaccine targeting tau

Axon Neuroscience reported encouraging long-term results from their phase II clinical trial, ADAMANT, for their Alzheimer's vaccine AADvac1. The vaccine, which targets the tau protein, showed a good safety profile and induced a robust immune response. Exploratory analysis suggested potential benefits on cognitive decline and reduction in certain disease biomarkers....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including AXON Neuroscience, are just a search away.